<DOC>
	<DOC>NCT01536002</DOC>
	<brief_summary>The objectives of this study are - To determine PK of propofol in bariatric patients - To identify the physiological variables that induce propofol PK changes in bariatric patients, when compared to a normal-weight population. - To define context-sensitive half-time profiles for propofol in bariatric patients.</brief_summary>
	<brief_title>Pharmacokinetics of Propofol in Morbidly Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Obesity, Morbid</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<criteria>Consecutive patients admitted to the Aker University Hospital, scheduled for general or bariatric surgery, Both genders. Female subjects of childbearing potential must be using adequate contraception (i.e. using oral or IM contraception or an IUCD) and must have a negative pregnancy test (urine betaHCG). Aged 18 60 years, both inclusive Body mass index (BMI) â‰¥ 20 kg/m2 Written informed consent Patients that are considered not to tolerate a standard dose of propofol administered as a bolus. Known hypersensitivity to propofol or its ingredients (soy, lecithin, glycerol, oil acid) Known hypersensitivity to any of the anesthetic agents to be used Pregnant women Lactating women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Bariatric surgery</keyword>
	<keyword>Anesthetics, intravenous</keyword>
	<keyword>Propofol</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>